FDA Inspection 1115086 — Zhejiang Dayang Biotech Group Co. Ltd.
The FDA completed an inspection of Zhejiang Dayang Biotech Group Co. Ltd. on Dec 19, 2019 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 19, 2019
- Fiscal Year
- 2020
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Hangzhou (China)